News Headlines Article

Stem cells reduce MS brain damage
San Diego Union-Tribune

In what could herald a major advance in treating multiple sclerosis, brain damage was significantly reduced in patients getting stem cell transplants, compared to a control group. Results of the small Phase 2 trial — the first of its kind — are preliminary but promising, according to experts not involved with the trial.

The four-year study compared the results of intense immune suppression followed by transplants of the patient’s own blood-forming, or hematopoietic stem cells to those of a control group given immune suppression alone.